Back
ESC Premium Access

Efficacy and safety of alirocumab in patients with multiple manifestations of cardiovascular disease (CVD): a post-hoc analysis of ODYSSEY program

Session: Lipids and platelets
Topic: Lipids
Speaker: Professor K. Ray (London, GB)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
77 presentations
11 followers

6 more presentations in this session

Inhibition of lipopolysaccharide induced gene expression by HDL from healthy subjects and patients with acute myocardial infarction

Speaker: Assistant Professor S. Imaizumi (Fukuoka, JP)

Access
Abstract
Thumbnail

Association of the postprandial chylomicron triglyceride/apoB index and cardiovascular events

Speaker: Doctor C. Werner (Homburg, DE)

Access
Abstract
Slides
Thumbnail

Malondialdehyde assay in evaluation of aspirin antiplatelet effects

Speaker: Mrs L. Dannenberg (Duesseldorf, DE)

Access
Abstract
Slides
Thumbnail

C2238 atrial natriuretic peptide molecular variant determines an increased platelet aggregation through the activation of NOX2 and the reduction of cAMP

Speaker: Assistant Professor S. Sciarretta (Rome, IT)

Access
Abstract
Thumbnail

Impact of alirocumab on Lp(a) in individuals with and without moderate CKD

Speaker: Professor P. Toth (Baltimore, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Lipids and platelets

Speakers: Professor K. Ray, Assistant Professor S. Imaizumi, Doctor C. Werner, Mrs L. Dannenberg, Assistant Professor S. Sciarretta...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb